Agree Grusselt. For me the announcement has too much "anticipated" sales in it. Three times in one paragraph! In addition to your comments about Carl Zeiss, I suspect that commencement of anticipated Viewnvivo sales in April 2017 may prove optimistic, particularly given the typically long budgetary approval and purchase lead times of potential client's like government departments or institutions.
I think the sales time frame has already suffered since the re-listing capital raising just three months ago. Further slippage on the anticipated time frame would not surprise, in which case the "higher employee wages, operating costs, sales and marketing expenses" will start to hurt again. I think it is telling that they have had to confirm the use of funds for these particular items.
Jess
Agree Grusselt. For me the announcement has too much...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 14.0¢ | $71.49K | 479.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 6886 | 1 |
View Market Depth
| Last trade - 12.32pm 04/12/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
